ERIN BASS: Open Payments
NPI 1679046585 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,941 in 105 payments from 16 companies in 2025. Trend: 2023 $2,085 · 2024 $2,993 · 2025 $1,941
Food & beverage: $1,941
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $629 |
| Amgen Inc. | 29 | $303 |
| E.R. Squibb & Sons, L.L.C. | 5 | $129 |
| Janssen Biotech, Inc. | 6 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Mallinckrodt Hospital Products Inc. | 5 | $113 |
| PFIZER INC. | 6 | $104 |
| ANI Pharmaceuticals, Inc. | 4 | $89 |
| UCB, Inc. | 5 | $86 |
| Alexion Pharmaceuticals, Inc. | 2 | $62 |
Products named: RINVOQ, SKYRIZI, OTEZLA, TREMFYA, COSENTYX, ACTHAR, XELJANZ, ORENCIA.
Industry payments across MS — which companies pay providers there.
